A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

NCT06962839 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Edema

Interventions

DRUG: BI 1815368
DRUG: Placebo

Sponsor

Boehringer Ingelheim